When less is more: High-dose, short duration regimens and antibiotic resistance

International Journal of Clinical Practice

Volumn 62, Issue 9, 2008, Pages 1304-1305

  Stein, R A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; DAPTOMYCIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIUM ISOLATE; CLINICAL TRIAL; DRUG EFFICACY; DRUG MEGADOSE; EDITORIAL; GRAM NEGATIVE INFECTION; HUMAN; INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DRUG RESISTANCE, MICROBIAL; HUMANS; INFUSIONS, INTRAVENOUS; MULTICENTER STUDIES AS TOPIC; PENICILLINS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SKIN DISEASES, BACTERIAL; VANCOMYCIN;

EID: 49349117362     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2008.01866.x     Document Type: Editorial

References (17)

1. Diazgranados CA, Cardo DM, McGowan JE Jr. Antimicrobial resistance: international control strategies, with a focus on limited-resource settings. Int J Antimicrob Agents 2008 32: 1 9.
2. Alanis AJ. Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res 2005 36: 697 705.
3. Giordano P, Weber K, Gesin G et al. Skin and skin structure infections: treatment with newer generation fluoroquinolones. Ther Clin Risk Manag 2007 3: 309 17.
4. Bennett JB, Crook SJ, Shaw EJ et al. A randomized double blind controlled trial comparing two amoxycillin regimens in the treatment of acute exacerbations of chronic bronchitis. J Antimicrob Chemother 1988 21: 225 32.
5. Poole M, Anon J, Paglia M, Xiang J, Khashab M, Kahn J. A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis. Otolaryngol Head Neck Surg 2006 134: 10 7.
6. Bergman AB, Werner RJ. Failure of children to receive penicillin by mouth. N Engl J Med 1963 268: 1334 8.
7. Kardas P, Devine S, Golembesky A et al. A systematic review and meta-analysis of misuse of antibiotic therapies in the community. Int J Antimicrob Agents 2005 26: 106 13.
8. Carey B, Cryan B. Antibiotic misuse in the community - a contributor to resistance? Ir Med J 2003 96: 43 4.
9. Kardas P. Patient compliance with antibiotic treatment for respiratory tract infections. J Antimicrob Chemother 2002 49: 897 903.
10. Pechère J-C, Hughes D, Kardas P et al. Non-compliance with antibiotic therapy for acute community infections: a global survey. Int J Antimicrob Agents 2007 29: 245 53.
11. Thomas JK, Forrest A, Bhavnani SM et al. Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother 1998 42: 521 7.
12. Nord CE, Oprica C. Antibiotic resistance in Propionibacterium acnes. Microbiological and clinical aspects. Anaerobe 2006 12: 207 10.
13. Dunbar LM, Wunderink RG, Habib MP et al. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis 2003 37: 752 60.
14. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998 26: 1 12.
15. Guillemot D, Carbon C, Balkau B et al. Low dosage and long treatment duration of beta-lactams: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 1998 279: 365 70.
16. Schrag SJ, Peña C, Fernández J et al. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial. JAMA 2001 286: 49 56.
17. Jumbe N, Louie A, Leary R et al. Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy. J Clin Invest 2003 112: 275 85.